Charles S. Ryan - Net Worth and Insider Trading
Charles S. Ryan Net Worth
The estimated net worth of Charles S. Ryan is at least $176,351 dollars as of 2025-03-16. Charles S. Ryan is the PRESIDENT of Quince Therapeutics Inc and owns about 122,461 shares of Quince Therapeutics Inc (QNCX) stock worth over $176,344. Charles S. Ryan is also the Director of BioRestorative Therapies Inc and owns about 4 shares of BioRestorative Therapies Inc (BRTX) stock worth over $7. Details can be seen in Charles S. Ryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles S. Ryan has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles S. Ryan
Charles S. Ryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles S. Ryan owns 4 companies in total, including Neurotrope Inc (NTRP) , Applied DNA Sciences Inc (APDN) , and BioRestorative Therapies Inc (BRTX) among others .
Click here to see the complete history of Charles S. Ryan’s form 4 insider trades.
Insider Ownership Summary of Charles S. Ryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTRP | Neurotrope Inc | 2019-12-13 | director & Chief Executive Officer |
| APDN | Applied DNA Sciences Inc | 2018-03-15 | director |
| BRTX | BioRestorative Therapies Inc | 2015-12-07 | director |
 | | 2024-08-20 | President |
Charles S. Ryan Latest Holdings Summary
Charles S. Ryan currently owns a total of 2 stocks. Among these stocks, Charles S. Ryan owns 122,461 shares of Quince Therapeutics Inc (QNCX) as of August 20, 2024, with a value of $176,344 and a weighting of 100%. Charles S. Ryan also owns 4 shares of BioRestorative Therapies Inc (BRTX) as of December 7, 2015, with a value of $7 and a weighting of 0%.
Latest Holdings of Charles S. Ryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2024-08-20 | 122,461 | 1.44 | 176,344 |
| BRTX | BioRestorative Therapies Inc | 2015-12-07 | 4 | 1.77 | 7 |
Holding Weightings of Charles S. Ryan
Charles S. Ryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles S. Ryan has made a total of 1 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 48,387 shares on August 20, 2024, which cost Charles S. Ryan around $31,452.
According to the SEC Form 4 filings, Charles S. Ryan has made a total of 0 transactions in BioRestorative Therapies Inc (BRTX) over the past 5 years. The most-recent trade in BioRestorative Therapies Inc is the acquisition of 2 shares on December 7, 2015, which cost Charles S. Ryan around $25,000.
Insider Trading History of Charles S. Ryan
- 1
Charles S. Ryan Trading Performance
GuruFocus tracks the stock performance after each of Charles S. Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles S. Ryan is 72.69%. GuruFocus also compares Charles S. Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles S. Ryan within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles S. Ryan's insider trading performs compared to the benchmark.
Performance of Charles S. Ryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.15 | | | | | |
| Relative Return to S&P 500(%) | 12.26 | | | | | |
Charles S. Ryan Ownership Network
Ownership Network List of Charles S. Ryan
Ownership Network Relation of Charles S. Ryan
Charles S. Ryan Owned Company Details
What does Neurotrope Inc do?
Who are the key executives at Neurotrope Inc?
Charles S. Ryan is the director & Chief Executive Officer of Neurotrope Inc. Other key executives at Neurotrope Inc include COO and General Counsel Michael Ciraolo , See Remarks Robert Weinstein , and See Remarks Daniel L. Alkon .
Neurotrope Inc (NTRP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurotrope Inc Insider Transactions
Charles S. Ryan Mailing Address
Above is the net worth, insider trading, and ownership report for Charles S. Ryan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Charles S. Ryan's mailing address is: Stony Brook Ny 11790.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
